Following our recent announcement that Principal Naomi Pearce (Patent Star 2021) was honoured with a Managing IP (MIP) Patent Star 2021 awards, Pearce IP’s Special Counsel Patent Attorney Dr Jacinta Flattery-O’Brien has also been named by MIP as a Patent Star 2021.
Pearce IP also congratulates Special Counsel Dr Jacinta Flattery-O’Brien together with Principal Naomi Pearce .
Pearce IP’s Special Counsel Kate Legge says:
“We previously announced that Naomi Pearce had been honoured in the MIP IP Stars 2021 award, and are delighted to announce that Dr Jacinta Flattery-O’Brien has also received this honour.
In 4 short years, Pearce IP has set a new benchmark for the provision of IP services in Australia. Pearce IP’s lawyers and attorneys are very highly regarded by clients and peers, and this honour bestowed by Managing IP on Naomi Pearce and Dr Jacinta Flattery-O’Brien is a reflection of that very high regard.”
Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys to the pharmaceutical, biopharmaceutical and life sciences industries.
CEO, Executive Lawyer, Patent & Trade Mark Attorney
Naomi is the founder of Pearce IP, and is one of Australia’s leading IP practitioners. Ranked in virtually every notable legal directory, highly regarded by peers and clients, with a background in molecular biology, Naomi is market leading in the field of pharma/biopharma, biotechnology and animal health.
Underpinning Naomi's legal work is a deep understanding of the pharma/biopharma industries, resulting from 25 years' experience including as VP of IP in-house global pharma giants, Partner of a top-tier international law firm, and as the founding Principal of Pearce IP.
Jacinta Flattery-O'Brien PhD
Special Counsel, Patent Attorney
Jacinta is a trusted and recognised leader in biotech/pharma patenting, identified as an "IP Star" by the highly regarded Managing Intellectual Property Journal (MIP) for her expertise.
She is a registered patent attorney with 20 years' experience serving clients in the biotechnology, pharmaceutical and biopharmaceutical industries.
Special Counsel, Lawyer
Kate is an experienced IP and patent lawyer, providing IP leadership for pharmaceutical product development and commercialisation in global markets – from initial scoping through to post-launch.
She has developed and implemented global IP strategies over more than 15 years at multi-national pharmaceutical companies. She is an Australian qualified and registered legal practitioner, and has a Master’s degree in IP Law and a BSc in biochemistry.